Our findings highlight a novel mechanism of constant Notch3 signaling activation in NPC metastasis, and suggest IGF2BP3 as a potent prognostic biomarker and a potential target against progressive metastasis in NPC. The gene discussed is NOTCH3; the disease is nasopharyngeal carcinoma.